The ADDF is closely monitoring and responding to the rapidly evolving COVID-19 pandemic as labs and biotech companies around the world face unprecedented challenges. The ADDF understands that this uncertain environment raises questions and concerns from our partners, funded investigators and interested applicants. We have compiled some answers below and will continue to update these as new information becomes available.

For Applicants:

I would like to discuss my program with a member of the scientific staff before I submit my application. Can I call the office?

Our staff is currently working remotely, but we encourage you to reach out with questions. Please visit our funding opportunities page for a list of Requests for Proposals (RFP) and email the scientific contact listed on the relevant RFP to discuss your proposal or schedule a call.

What if I am unable to submit my letter of intent/invited full proposal in time for the next deadline?

We understand there may be delays in submitting applications. We will consider an extension if delays are anticipated. Please email the scientific contact listed on the relevant RFP to discuss further.

My proposal is currently under active review by the ADDF. Will this process be delayed?

We are not anticipating major delays in our review process; however, if this changes, we will notify you.

For Funded Investigators:

I am anticipating delays or disruptions in my ADDF-funded project. What should I do?

We understand that many aspects of research will be delayed or disrupted due to the evolving COVID-19 situation. We will consider no-cost extensions or other adaptations if needed. Please email your scientific point person directly to discuss your concerns. If you do not know your scientific point person, please email

Will I still continue to receive payments?

The ADDF is honoring all funding commitments as outlined in your finalized funding agreement. We do not anticipate disruptions in releasing payments. Please email if you have questions.

What if I need additional time to complete my scientific and financial reports?

You will continue to receive automated email reminders about reporting deadlines during this time. However, we understand that you may need additional time to submit scientific and/or financial reports. If you anticipate needing an extension, please email your scientific point person directly. If you do not know your scientific point person, please email

For Scientific and Business Reviewers:

I indicated my availability for an upcoming panel review. Will the ADDF still be holding panels?

We are aiming to hold all upcoming panel reviews and hope you will be able to participate via teleconference as usual. We will continue to monitor the situation and will let reviewers know of any changes. Please keep us updated on your plans or if anything is changing by emailing (This will help us plan for the panel as best we can).

About Our Scientific Meetings:

Are you still holding the Drug Discovery for Neurodegeneration Workshop? 

The 14th Annual Drug Discovery for Neurodegeneration Workshop will now be held as an entirely virtual meeting. In place of the in-person event, we are now planning to host the meeting online with virtual presentations and opportunities to interact with each other through an online platform. We’ll share additional details on our plans in the coming weeks.  Please visit the conference website for more information. For questions about the virtual meeting, please email

I am interested in attending the International Conference on Alzheimer’s Drug Discovery scheduled for October. Will the meeting take place?

This annual conference is currently scheduled to proceed as an in-person meeting on October 5-6, 2020 in Jersey City, NJ. In the coming weeks and months, we will closely monitor the COVID-19 situation and will adjust accordingly. Please continue to check our conference website for updated information.

Other Questions:

I have a question that is not listed here. 

Please contact with your question, and it will be directed to the appropriate staff member.